Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting | Zendy

Luis Caballero | Zendy; J. M. Ruiz-Nodar | Zendy; Francisco Marı́n | Zendy; Vanessa Roldán | Zendy; Julio Hurtado | Zendy; José Valencia | Zendy; Sergio ManzanoFernández | Zendy; Francisco Sogorb | Zendy; M. Valdés | Zendy; Gregory Y.H. Lip | Zendy

Open Access

Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

Author(s) -

Luis Caballero,

J. M. Ruiz-Nodar,

Francisco Marı́n,

Vanessa Roldán,

Julio Hurtado,

José Valencia,

Sergio ManzanoFernández,

Francisco Sogorb,

M. Valdés,

Gregory Y.H. Lip

Publication year - 2012

Publication title -

age and ageing

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.014

H-Index - 143

eISSN - 1468-2834

pISSN - 0002-0729

DOI - 10.1093/ageing/afs121

Subject(s) - medicine , mace , percutaneous coronary intervention , conventional pci , atrial fibrillation , myocardial infarction , cardiology , warfarin , surgery

a significant proportion of octogenarian patients with atrial fibrillation (AF) undergo percutaneous coronary intervention (PCI) with stenting. Dual antiplatelet therapy is recommended in these patients, requiring a period of triple therapy with dual antiplatelet agent plus oral anticoagulation (OAC). Concerns remain regarding the appropriateness of OAC in octogenarians.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research